China Journal of Leprosy and Skin Diseases ›› 2026, Vol. 42 ›› Issue (11): 826-830.doi: 10.12144/zgmfskin202611826

• Reviews • Previous Articles    

Research progress of platelet-rich plasma in the treatment of vitiligo

ZUO Wenjia1, MA Hong2, ZHOU Hucheng2, LIU Zizhong1   

  1. 1 The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China; 2 Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
  • Online:2026-11-15 Published:2026-10-29

Abstract: Platelet-rich plasma (PRP) is rich in a variety of growth factors and cytokines. It can promote the proliferation and migration of melanocytes, inhibit local immune-inflammatory responses, improve cell adhesion and skin microenvironment, and thus facilitate repigmentation of lesions, showing promising application potential in the treatment of vitiligo. This review summarizes the biological basis, clinical research, potential mechanisms, and limitations of PRP in vitiligo treatment, to provide a reference for further research and clinical application of PRP in vitiligo.

Key words: platelet-rich plasma, vitiligo, melanocytes, immune regulation